Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.

[1]  A. Telenti,et al.  Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level , 1997, Journal of clinical microbiology.

[2]  J. Musser,et al.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[3]  I. Mokrousov,et al.  Detection of embB306 Mutations in Ethambutol-Susceptible Clinical Isolates of Mycobacterium tuberculosis from Northwestern Russia: Implications for Genotypic Resistance Testing , 2002, Journal of Clinical Microbiology.

[4]  D. Wilkinson.  Anti-tuberculosis drug resistance in the world: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva: World Health Organization, 1997. 228pp. Price Sw. fr 25/US$22.50 (in developing countries Sw. fir 17.50). (Reference WHO/TB/97.229) , 1998 .

[5]  P. V. van Helden,et al.  Prediction of Drug Resistance in M. tuberculosis: Molecular Mechanisms, Tools, and Applications , 2002, IUBMB life.

[6]  Annelies Van Rie,et al.  Analysis for a Limited Number of Gene Codons Can Predict Drug Resistance of Mycobacterium tuberculosis in a High-Incidence Community , 2001, Journal of Clinical Microbiology.

[7]  C. E. Barry,et al.  The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. , 2000, Microbes and infection.

[8]  T. Pennington,et al.  Rifampin resistance in Neisseria meningitidis due to alterations in membrane permeability , 1996, Antimicrobial agents and chemotherapy.

[9]  T. Whittam,et al.  Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  F. Portaels,et al.  Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[11]  E. Böttger,et al.  Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis , 1996, Antimicrobial agents and chemotherapy.

[12]  D van Soolingen,et al.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology , 1997, Journal of clinical microbiology.

[13]  H. Aramaki,et al.  Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. , 1996, FEMS microbiology letters.

[14]  J. T. Crawford,et al.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology , 1993, Journal of clinical microbiology.

[15]  J H Lee,et al.  Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[16]  L. Schouls,et al.  A low cost, home-made, reverse-line blot hybridisation assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  Audrey S. M. Teo,et al.  Novel Mutations in ndh in Isoniazid-Resistant Mycobacterium tuberculosisIsolates , 2001, Antimicrobial Agents and Chemotherapy.

[18]  P. Kiepiela,et al.  Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. , 2000, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[19]  A. Telenti,et al.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis , 1993, The Lancet.

[20]  M. Filipenko,et al.  Detection of Isoniazid-Resistant Mycobacterium tuberculosis Strains by a Multiplex Allele-Specific PCR Assay Targeting katG Codon 315 Variation , 2002, Journal of Clinical Microbiology.

[21]  E. Bayerdörffer,et al.  Rifampin and Rifabutin Resistance Mechanism inHelicobacter pylori , 1999, Antimicrobial Agents and Chemotherapy.

[22]  D. Rouse,et al.  Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis , 1997, Antimicrobial agents and chemotherapy.

[23]  K. Severinov,et al.  Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase. , 1993, Journal of Biological Chemistry.

[24]  A. Telenti,et al.  The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol , 1997, Nature Medicine.

[25]  P. V. van Helden,et al.  Sequence Polymorphism in the rrs Gene ofMycobacterium tuberculosis Is Deeply Rooted within an Evolutionary Clade and Is Not Associated with Streptomycin Resistance , 2001, Journal of Clinical Microbiology.

[26]  K. Feldmann,et al.  Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance in Mycobacterium tuberculosis. , 1997, Molecular and cellular probes.

[27]  M. L. Ricci,et al.  rpoB Mutations in Multidrug-Resistant Strains of Mycobacterium tuberculosis Isolated in Italy , 1999, Journal of Clinical Microbiology.

[28]  S. Niemann,et al.  Frequency of rpoB Mutations Inside and Outside the Cluster I Region in Rifampin-Resistant Clinical Mycobacterium tuberculosis Isolates , 2001, Journal of Clinical Microbiology.

[29]  S. Gillespie,et al.  Physiological Cost of Rifampin Resistance Induced In Vitro in Mycobacterium tuberculosis , 1999, Antimicrobial Agents and Chemotherapy.

[30]  C. Çavuşoğlu,et al.  Characterization of rpoB Mutations in Rifampin-Resistant Clinical Isolates of Mycobacterium tuberculosis from Turkey by DNA Sequencing and Line Probe Assay , 2002, Journal of Clinical Microbiology.

[31]  D. Sherman,et al.  Biochemical and genetic data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis. , 1996, The Journal of infectious diseases.

[32]  Sang-Nae Cho,et al.  Molecular Detection of Early Appearance of Drug Resistance during Mycobacterium tuberculosis Infection , 2002, Clinical chemistry and laboratory medicine.

[33]  E. Böttger,et al.  Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot , 1993, Molecular microbiology.

[34]  M G Reynolds,et al.  Compensatory evolution in rifampin-resistant Escherichia coli. , 2000, Genetics.

[35]  X. Zhang,et al.  Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates. , 1999, Chinese medical journal.

[36]  F. Cockerill.  Genetic Methods for Assessing Antimicrobial Resistance , 1999, Antimicrobial Agents and Chemotherapy.